Molecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19

References

• Amin, S. A., & Jha, T. (2020). Fight against novel coronavirus: A perspective of medicinal chemists. European Journal of Medicinal Chemistry, 201, 112559. https://doi.org/https://doi.org/10.1016/j.ejmech.2020.112559
   PubMed Web of Science ®Google Scholar
• Amudha, M., & Rani, S. (2016). In silico molecular docking studies on the phytoconstituents of cadaba fruticosa (L.) druce for its fertility activity. Asian Journal of Pharmaceutical and Clinical Research, 9, 48–50.
   Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.)), 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
   PubMed Web of Science ®Google Scholar
• Anoop, K., Varun, T. K., Ajeesh, A. K., Aravind, A., Muhammad Azharuddin, M., Praveen, P., Sayeed Ali, M. P., J., Variyar, E. (2020). Screening of potential inhibitors for COVID-19 main protease from phytoconstituents of Tectona grandis Linn: Application of molecular modeling studies. https://doi.org/https://doi.org/10.21203/rs.3.rs-21617/v1
   Google Scholar
• Awoniyi, O. (2020). The petri-dish effect. disaster med. Public Health Prep, 1–2. https://doi.org/https://doi.org/10.1017/dmp.2020.67
   Google Scholar
• Basalingappa, K. M. (2017). Tinospora cordifolia: The antimicrobial property of the leaves of amruthaballi. Journal of Bacteriology & Mycology: Open Access, 5(5), 363-371. https://doi.org/https://doi.org/10.15406/jbmoa.2017.05.00147
   Google Scholar
• Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation, and treatment of Coronavirus (COVID-19). In StatPearls. Treasure Island (FL): StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK554776/
   Google Scholar
• Chowdhury, P. (2020). In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia (giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach. Journal of Biomolecular Structure and Dynamics, 0, 1–18. https://doi.org/https://doi.org/10.1080/07391102.2020.1803968
   Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 1–13. https://doi.org/https://doi.org/10.1038/srep42717
   Google Scholar
• Gopal Samy, B., & Xavier, L. (2015). Molecular docking studies on antiviral drugs for SARS. International Journal of Advanced Research in Computer Science and Software Engineering, 5, 75-79.
   Google Scholar
• Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., Penzar, D., Perlman, S., Poon, L. L. M., Samborskiy, D. V., Sidorov, I. A., Sola, I., & Ziebuhr, J, Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, (2020). The species severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5, 536–544. https://doi.org/https://doi.org/10.1038/s41564-020-0695-z
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1751300
   PubMedGoogle Scholar
• Ji, Y., Ma, Z., Peppelenbosch, M. P., & Pan, Q. (2020). Potential association between COVID-19 mortality and health-care resource availability. The Lancet. Global Health, 8(4), e480. https://doi.org/https://doi.org/10.1016/S2214-109X(20)30068-1
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 0, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577
   Google Scholar
• Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• McBride, R., van Zyl, M., & Fielding, B. C. (2014). The Coronavirus Nucleocapsid Is a Multifunctional Protein. Viruses, 6(8), 2991–3018. https://doi.org/https://doi.org/10.3390/v6082991
   PubMed Web of Science ®Google Scholar
• Mousavizadeh, L., & Ghasemi, S. (2020). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology and Infection, 1-5. https://doi.org/https://doi.org/10.1016/j.jmii.2020.03.022
   Google Scholar
• Muchtaridi, M., Fauzi, M., Khairul Ikram, N. K., Mohd Gazzali, A., & Wahab, H. A. (2020). Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2. Molecules, 25(17), 3980. https://doi.org/https://doi.org/10.3390/molecules25173980
   PubMed Web of Science ®Google Scholar
• Ng, W. L. (2020). To lockdown? When to peak? Will there be an end? A macroeconomic analysis on COVID-19 epidemic in the United States. Journal of Macroeconomics, 65, 103230 https://doi.org/https://doi.org/10.1016/j.jmacro.2020.103230
   PubMed Web of Science ®Google Scholar
• Panahi, L., Amiri, M., & Pouy, S. (2020). Risks of novel coronavirus disease (COVID-19) in pregnancy; a narrative review. Archives of Academic Emergency Medicine, 8, 1-5.
   Google Scholar
• Parasuraman, P., Swaminathan, S., & Dhanaraj, P. (2014). Balancing anti-amyloid and anti-cholinesterase capacity in a single chemical entity: InSilico drug design. International Journal of Pharmacy and Pharmaceutical Sciences, 2, 571–574.
   Google Scholar
• Patel, S. K., Singh, R., Rana, J., Tiwari, R., Natesan, S., Harapan, H., Arteaga-Livias, K., Bonilla-Aldana, D. K., Rodríguez-Morales, A. J., & Dhama, K. (2020). The kidney and COVID-19 patients - Important considerations. Travel Medicine and Infectious Disease, 37, 101831. https://doi.org/https://doi.org/10.1016/j.tmaid.2020.101831
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Schrödinger, LLC (2015). The PyMOL Molecular Graphics System, Version 1.8.
   Google Scholar
• Tahir Ul Qamar, M., Maryam, A., Muneer, I., Xing, F., Ashfaq, U. A., Khan, F. A., Anwar, F., Geesi, M. H., Khalid, R. R., Rauf, S. A., & Siddiqi, A. R. (2019). Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus. Scientific Reports, 9(1), 1433. https://doi.org/https://doi.org/10.1038/s41598-018-38450-1
   PubMedGoogle Scholar
• Tripathi, M. K., Singh, P., Sharma, S., Singh, T. P., Ethayathulla, A. S., & Kaur, P. (2020). Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1790425
   Google Scholar
• Wang, H., Yang, P., Liu, K., Guo, F., Zhang, Y., Zhang, G., & Jiang, C. (2008). SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Research, 18(2), 290–301. https://doi.org/https://doi.org/10.1038/cr.2008.15
   PubMed Web of Science ®Google Scholar
• Yi, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020). COVID-19: What has been learned and to be learned about the novel coronavirus disease. International Journal of Biological Sciences, 16(10), 1753–1766. https://doi.org/https://doi.org/10.7150/ijbs.45134
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science, 368, 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016). Coronaviruses – drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347. https://doi.org/https://doi.org/10.1038/nrd.2015.37
   PubMed Web of Science ®Google Scholar